Categories
Blog

Understanding the Differences Between a Health Canada Drug Monograph and Product Monograph – A Must-Know Guide

Navigating Canada’s pharmaceutical regulations can be overwhelming for businesses, especially those dealing in food products, ingredients, and additives. Two pivotal documents in this regulatory landscape—the Health Canada Drug Monograph and Product Monograph—hold distinct roles and purposes. Understanding these differences is crucial for any business looking to introduce food-related products or other regulated substances into the Canadian market. When preparing these essential documents, Quality Smart Solutions is your expert partner, ensuring your submission is accurate, complete, and compliant, ultimately helping to fast-track your product to market.  

In this article, we break down the key differences between a Health Canada Drug Monograph and a Product Monograph, emphasizing why knowing these distinctions can be the difference between quick market access and costly delays. Let’s dive in!  

What is a Health Canada Drug Monograph?  

A Health Canada Drug Monograph serves as a regulatory framework set by Health Canada that outlines the pre-approved conditions for selling specific classes of drugs, typically non-prescription, without needing clinical trials. This guide is handy for companies dealing with non-prescription or over-the-counter products, as it provides a standardized way to bring these items to market with reduced time and financial investment.  

Critical Characteristics of Health Canada Drug Monographs:  

Predefined Standards  

Health Canada Drug Monographs include predefined dosages, indications, and labelling standards that manufacturers must follow. These monographs enable manufacturers to market products in specified categories without a full clinical trial.  

Simplified Approval Process  

Products that fit within these predefined standards can bypass the clinical trial requirement, making it a cost-effective and time-efficient path to the market.  

Common Examples  

Common categories include pain relievers, antihistamines, and cough suppressants. The approval process is far more straightforward for products that meet monograph standards.  

Why Are Drug Monographs Important?  

Drug monographs streamline product approval by providing a clear pathway with pre-approved guidelines. They allow manufacturers to move forward quickly while ensuring products remain safe and compliant under Health Canada’s established regulations.  

What is a Product Monograph?  

Unlike the Drug Monograph, a Product Monograph is a comprehensive, specific document that companies must submit to Health Canada to market a new prescription or over-the-counter drug requiring unique clinical data. This document details how a particular drug is used and prescribed, serving as a crucial reference for healthcare professionals.  

Critical Characteristics of Product Monographs:  

Detailed Clinical Data Required  

Unlike a Drug Monograph, a Product Monograph demands extensive clinical data, including safety, efficacy, and dosage. This information is essential for Health Canada to evaluate the risks and benefits of a specific drug.  

Three-Part Structure  

A Product Monograph is divided into:  

  • Part I: Health Professional Information – Prescribing details for professionals.  
  • Part II: Scientific Information – Clinical trial results, safety, and pharmacodynamics.  
  • Part III: Consumer Information – User-friendly instructions on safe drug use for consumers.  

Uniqueness of Each Product  

Product Monographs are exclusive to the specific drug they cover, unlike Drug Monographs that apply to a whole class of drugs.  

Why is a Product Monograph Important?  

Product Monographs are critical in ensuring that healthcare providers have comprehensive knowledge of a drug’s safety, risks, and prescribing guidelines. This document is essential for achieving regulatory approval from Health Canada for prescription drugs.  

Critical Differences Between Health Canada Drug Monographs and Product Monographs  

To simplify, here are the four main distinctions:
 

  • Purpose 

a. Health Canada Drug Monograph: Offers a pre-approved, standardized approach for classes of drugs. 

b. Product Monograph: Details all aspects of a unique drug’s safety, efficacy, and instructions. 

  • Scope of Coverage 

a. Drug Monograph: Applies to broad classes (e.g., pain relievers). 

b. Product Monograph: Applies to a specific drug only. 

  • Clinical Data Requirement 

a. Drug Monograph: No new clinical data required. 

b. Product Monograph: Extensive data and clinical trial results needed. 

  • Approval Time to Market 

a. Drug Monograph: Faster approval, lower regulatory burden. 

b. Product Monograph: Longer review process due to the need for comprehensive data. 

Frequently Asked Questions  

Why are Health Canada Drug Monographs Faster to Approve?  

Answer: Because they don’t require new clinical trials, these monographs offer a quicker path to market for products that fit pre-approved categories.  

Does Every Drug Need a Product Monograph?  

Answer: No, only drugs that are prescription-based or require unique clinical evidence need a Product Monograph.  

Can a Product Have Both Types of Monographs?  

Answer: Typically, no. A drug falls into a class requiring a Drug Monograph or a detailed, unique Product Monograph.   

How Quality Smart Solutions Can Help  

Quality Smart Solutions specializes in helping businesses navigate Canada’s complex regulatory landscape. With expertise in Health Canada Drug Monographs and Product Monographs, their team ensures every submission is complete and compliant and fast-tracks your product to market. Reach out to us today by filling out the form below. 

Categories
News

FDA Fees Summary for 2025

FDA User Fees for Fiscal Year 2025 (FY2025) 

The FDA’s user fees for FY2025, which runs from October 1, 2024, to September 30, 2025, apply to various industries, including pharmaceuticals, medical devices, biologics, and animal drugs. These fees help support the FDA’s regulatory and review processes, promoting efficient approval and compliance. 

1. Prescription Drug User Fee Act (PDUFA) Fees 

For human prescription drugs and biologics, PDUFA fees expedite the drug approval process: 

  • New Drug Application (NDA) with clinical data: $4,310,002 
  • NDA without clinical data: $2,155,001 
  • Program Fees (for approved drugs): $403,889 per product 

2. Medical Device User Fee Amendments (MDUFA) Fees 

MDUFA fees apply to medical devices to support review and regulation: 

  • 510(k) Premarket Notification Submission: $24,335 
  • Premarket Approval (PMA) Application: $540,783 
  • De Novo Classification Request: $162,235 
  • Annual Establishment Registration Fee: $9,280 

3. Generic Drug User Fee Amendments (GDUFA) Fees 

GDUFA applies to generic drug manufacturers to enhance the generic application review process: 

  • Abbreviated New Drug Application (ANDA) Fee: $252,453 
  • Program Fees: 
    • Large companies (20+ approved ANDAs): $1,891,664 
    • Medium companies (6-19 ANDAs): $756,666 
    • Small companies (1-5 ANDAs): $189,166 

4. Biosimilar User Fee Act (BsUFA) Fees 

BsUFA fees are for biosimilar biological products to aid in regulatory review: 

  • Application Fee (with clinical data): $1,471,118 
  • Application Fee (without clinical data): $735,559 
  • Biosimilar Program Fee: $256,168 

5. Animal Drug User Fee Act (ADUFA) Fees 

ADUFA fees apply to veterinary drug manufacturers: 

  • Animal Drug Application (NADA): $581,735 
  • Supplement requiring safety or efficacy data: $290,867 
  • Annual Product Fee: $10,705 
  • Annual Establishment Fee: $157,702 

6. Animal Generic Drug User Fee Act (AGDUFA) Fees 

AGDUFA supports generic animal drug manufacturers: 

  • Abbreviated New Animal Drug Application (ANADA): $161,907 
  • Annual Product Fee: $116,139 
  • Annual Establishment Fee: $157,702 

7. Over-The-Counter (OTC) Monograph Drug User Fee 

Fees for non-prescription drugs marketed under OTC monographs: 

  • OTC Monograph Order Request (Tier 1): $559,777 
  • OTC Monograph Order Request (Tier 2): $111,955 
  • Annual OTC Monograph Drug Facility Fees: 
    • Monograph Drug Facility (MDF): $34,166 
    • Contract Manufacturing Organization (CMO) MDF: $22,777 

Key Notes 

  • Establishment Fees: Annual registration fees apply to industries like medical devices, prescription drugs, and animal drugs. 
  • Small Business Reductions: Some fees may be reduced for small businesses in medical devices and pharmaceuticals that meet eligibility criteria. 
  • Annual Adjustments: The FDA reviews and adjusts these fees annually based on inflation and regulatory demands to improve review efficiency and post-market safety. 

How Quality Smart Solutions Can Help 

Keeping up with regulatory fees and submission requirements is crucial for your business’s success in FDA-regulated industries. Quality Smart Solutions is here to simplify the registration and compliance process for your company, whether you’re working with the FDA, Health Canada, or the European Food Safety Authority (EFSA). Contact Quality Smart Solutions today to ensure smooth, cost-effective compliance that aligns with the latest regulatory standards. 

Categories
Blog

New Modification to Buffer Zone Affects Food Manufacturers and Suppliers

Simplified Explanation of Changes to Labeling Rules 

Starting July 2022, food manufacturers and suppliers have been required to display special labeling symbols on certain food products. These include a front-of-package (FOP) nutrition symbol for products high in saturated fat, sugar, or sodium, and a supplemented food caution identifier (SFCI) for supplemented foods with specific health or safety concerns (e.g. added caffeine). Some products may require both symbols on the front of the package, which has caused concerns about space on labels and packaging design. 

Why Was a Change Needed? 

Manufacturers and suppliers raised concerns that placing both symbols on the packaging would take up too much space, leaving less room for other important information. To address this concern, Health Canada modified the rules to allow these symbols to be placed directly next to each other without a gap between them. This is especially helpful for products that need more than one FOP nutrition symbol or both the FOP symbol and the SFCI. 

What Has Changed? 

Before this change, there was a required empty space, or “buffer zone,” around each symbol. Now, if the FOP nutrition symbol and the SFCI are next to each other, there doesn’t need to be a gap where they touch. This also applies to products needing multiple FOP symbols. However, any remaining sides of the symbols not touching another symbol must still have the required space around them. 

How This Affects Food Manufacturers 

This modification gives manufacturers and suppliers more flexibility in how they design their labels. They can now place these symbols side-by-side without worrying about taking up too much space, while still meeting legal requirements. This helps reduce the impact on available label space, making it easier for manufacturers and suppliers to comply with the rules, while still maintaining their brand integrity and marketing design. 

Next Steps 

The change was finalized after Health Canada received feedback from industry representatives and other stakeholders. This adjustment should make it easier for manufacturers to follow labeling guidelines while maintaining the integrity of the symbols for consumers. This update allows more efficient use of space on food packaging while keeping important health information visible and clear. 

Quality Smart Solutions Can Help

Navigating the latest labeling requirements can be challenging, but Quality Smart Solutions is here to simplify the process. With recent changes to Canada’s labeling rules, Quality Smart Solutions offers expert guidance to ensure your labels meet these updated requirements efficiently and effectively. Let us help you create compliant, clear, and consumer-friendly labels that uphold the integrity of your brand. Reach out to Quality Smart Solutions to streamline your labeling process and stay ahead in the industry. Fill out the form below to get started.

 s

Categories
News Press Releases

Quality Smart Solutions Launches GRAS Experts to Protect Against Food Safety Risks

GRAS Experts, a new division aimed at tackling ingredient safety concerns and helping businesses stay ahead of regulatory changes and avoiding recalls

In light of McDonald’s recent recall of Quarter Pounders due to E. coli contamination, the need for stringent oversight on food ingredients has never been more critical. Quality Smart Solutions has launched GRAS Experts, a new division aimed at tackling ingredient safety concerns and helping businesses stay ahead of regulatory changes and avoiding recalls.

“Everyone’s talking about food safety right now, and for good reason,” said Andrew Parshad, President & Founder of Quality Smart Solutions. “The McDonald’s recall is a stark reminder of what can happen when ingredient or food safety isn’t airtight. GRAS Experts was created to help businesses avoid these exact scenarios by ensuring their ingredients are proven safe and fully compliant with evolving regulations.”

As more companies face scrutiny over what goes into their products, the GRAS (Generally Recognized as Safe) process has become a critical standard for ingredient approval. GRAS Experts simplifies this complicated process, providing businesses with expert guidance to secure GRAS status for their ingredients, navigate Health Canada approvals, and meet EFSA Novel Food regulations.

Additionally, the Toxic Free Food Act just introduced, complicates the compliance process. The issue being the self affirmed GRAS pathway (not filing with FDA) gives any novel ingredient supplier the ability to put together a dossier or evidence without a government agency vetting it. The Act proposes to end that and require that novel ingredients mandatorily be filed with FDA. GRAS Experts was designed to successfully navigate this process.

With a dedicated team of regulatory specialists, GRAS Experts takes the stress out of compliance, helping food manufacturers and ingredient suppliers prevent costly recalls and protect their reputation.

In a time when consumers are more concerned than ever about what’s in their food, Quality Smart Solutions is stepping up to ensure businesses can deliver products that meet the highest safety standards. GRAS Experts is not just about compliance—it’s about trust.

Read the News Release on GlobalNewsWire

Categories
Blog

Government of Canada Launches Consultation on Plant-Based Egg Alternative Labelling: What Businesses Need to Know

The Canadian Food Inspection Agency (CFIA) has launched a 90-day consultation on proposed guidance for labelling plant-based alternatives to egg products, a critical development for businesses involved in Novel Food Products and ingredients. As the plant-based food market skyrockets, this new consultation presents both an opportunity and a challenge for companies to ensure their products meet compliance standards. Businesses must now navigate the complex landscape of food labelling, and the right strategy can make all the difference. If you’re in the plant-based or novel food space, this consultation is something you can’t afford to ignore.

The Growing Importance of Clear Food Labelling

With plant-based foods booming, clarity in labelling is essential for legal compliance and consumer trust. The Government of Canada’s proposed guidelines seek to ensure that plant-based alternatives to egg products are labelled truthfully and are not misleading to consumers. These guidelines are vital as more people turn to plant-based diets and expect transparency in the products they purchase. But how can businesses keep up with the ever-evolving regulations in the food industry?

If you’re a company that deals with Novel Food Products or innovative plant-based alternatives, now is the time to act. Ensuring compliance with new labelling standards will protect your brand from legal challenges and boost your reputation for honesty and transparency. Are you prepared for this shift?

Why This Matters for Businesses in the Novel Food Space

The plant-based food sector is no longer niche—it’s mainstream, and the competition is fierce. The CFIA’s consultation focuses on creating clear distinctions between plant-based alternatives and traditional egg products. Businesses need to get ahead by revisiting their product labels to ensure they meet the proposed guidelines while standing out in a crowded marketplace.

So, what does this mean for you?

If your company deals in plant-based or novel food products, you are entering a complex compliance maze. The terms, images, and packaging design must be clear and non-misleading. Simple errors could lead to consumer confusion, a damaged brand image, or even costly legal ramifications.

Here’s where it gets more complicated: the CFIA is not just asking for feedback from businesses but also asking for input from consumers. Consumer perception of your product is under the microscope, and businesses must consider how their labels resonate with the end-user.

Now, more than ever, it’s essential to ask: Is your product being perceived in the right way?

The Stakes Are High—Don’t Let Your Brand Get Left Behind

According to the CFIA, this consultation aims to “help the industry comply with the legislation and support consistency in how these foods are promoted.” For companies, this means adopting clear and honest labels that don’t mislead consumers. While the proposed guidance provides tools like the Industry Labelling Tool to help businesses, it’s not just about following the rules—it’s about staying ahead of them.

This consultation ends on October 28, 2024, giving businesses a narrow window to evaluate their labelling practices and prepare for potential changes.

Is your company prepared to handle the upcoming changes in labelling regulations?

How Quality Smart Solutions Can Help You Navigate This Complex Process

Having a trusted partner like Quality Smart Solutions can make all the difference when dealing with regulatory changes, especially those involving novel and plant-based foods. Navigating the maze of CFIA compliance and staying updated on evolving standards can be daunting. That’s why businesses need expert guidance to ensure their products are compliant and competitive. Quality Smart Solutions specializes in helping companies meet GRAS (Generally Recognized as Safe), Health Canada, and CFIA standards, ensuring your product stays on the shelf and in consumers’ good graces.

Final Thoughts: You Must Ensure Compliance and Consumer Trust

The CFIA’s new consultation on plant-based egg alternatives is critical for businesses involved in Novel Food Products and plant-based alternatives. It’s an opportunity to strengthen your brand’s reputation by showing consumers you’re serious about transparency and safety. But the window for action is short, and the stakes are high.

How Quality Smart Solutions Can Help

With a deep understanding of food regulations, Quality Smart Solutions offers expert guidance in navigating compliance for plant-based alternatives and Novel Food Products. Whether you aim to meet CFIA standards or require help with Health Canada approvals, they provide tailor-made solutions to ensure your product is compliant and market-ready. Reach out to QSS today by filling out the form below.

Categories
News

New Hydration Product Monographs Launched

The NNHPD Opens Consultation on Batch 4 

Through new guidelines, stakeholders are invited to shape the future of homeopathic and topical health products. 

The Natural and Non-Prescription Health Products Directorate (NNHPD) has made a significant announcement, opening a crucial consultation period for Batch 4 of their latest product monographs, including several that will impact the growing market for hydration-related health products. This new development is not just about regulatory changes—it represents an opportunity for stakeholders to influence the standards governing these products directly, ensuring they are both safe and effective for consumers. For companies and professionals in the natural health sector, this consultation is a chance to align their products with the latest health regulations, cement their place in a rapidly evolving market, and contribute to the overall advancement of health product innovation. 

Why These New Hydration Monographs Matter 

The release of the new monographs has implications beyond simple regulatory compliance. With health-conscious consumers seeking more natural solutions for hydration, the products covered in Batch 4a, particularly those related to homeopathic remedies and topical treatments, offer companies an opportunity to meet growing demand confidently. Hydration products are now a central part of self-care routines, and the NNHPD’s focus on these products demonstrates their significance in the modern health landscape. 

According to experts at Quality Smart Solutions, leading consultants in regulatory affairs, these monographs play a critical role in setting product safety, efficacy, and consumer trust standards. Companies that integrate these regulations into their hydration product development can expect to meet compliance requirements and strengthen their credibility in a competitive market. 

A Closer Look at New Homeopathic Hydration Monographs 

Batch 4a introduces six homeopathic-like monographs, particularly relevant to hydration products aimed at maintaining and restoring fluid balance in the body. Homeopathy, a system of alternative medicine, is gaining momentum in wellness circles, and hydration-focused homeopathic products are poised to address a variety of consumer needs—from electrolyte balance to skin hydration. 

These monographs are a crucial development for manufacturers looking to introduce innovative, natural hydration solutions. By adhering to the guidelines set out by the NNHPD, companies can ensure their products are both compliant and positioned to capitalize on the growing trend toward natural, non-prescription health products. 

In this consultation, stakeholders are encouraged to provide suggestions for revisions supported by published evidence or rationales. This collaborative process ensures that the final monographs are scientifically sound, practical for manufacturers, and beneficial for consumers. 

Batch 4b: Spotlight on Topical and Buccal Hydration Products 

While the homeopathic monographs in Batch 4a focus on internal hydration and fluid balance, Batch 4b, slated for release on November 1, will center around topical and buccal (oral mucosal) hydration products. With 17 single-ingredient topical/buccal monographs under review, this consultation will explore traditional plant-based ingredients used for hydration, from aloe vera to hyaluronic acid. 

Topical hydration products, such as moisturizers, serums, and gels, are essential for maintaining skin health, particularly in harsh climates and dry conditions. The new monographs will provide clear guidelines on the traditional quantity crude equivalent amount of these ingredients, ensuring that products using these ingredients are both practical and safe for consumer use. 

Buccal hydration products are equally important, particularly for individuals with specific hydration needs related to oral health. These products, often in sprays or lozenges, provide targeted hydration and relief, and the upcoming consultation will establish concentration guidelines that ensure their efficacy. 

A direct link to all the monographs in batch 4a and to the new monographs can be found here.   

Or copy and paste the link below: 

https://drive.google.com/drive/folders/1zOpHiShCS6VOWgJgW2fOCjw9pw4wkEyE?usp=sharing 

 

Your Chance to Shape the Future 

One of the most critical aspects of this consultation is its collaborative nature. The NNHPD is actively seeking input from industry professionals, manufacturers, and other stakeholders to ensure that the new hydration monographs are both scientifically accurate and practically applicable. This open consultation is a unique opportunity to influence the regulatory landscape for hydration products. 

The NNHPD encourages stakeholders to carefully review the monographs and provide comments by October 2, 2024, for Batch 4a and by January 14, 2025, for Batch 4b. These deadlines provide ample time for carefully considering the monographs, ensuring that feedback is comprehensive and informed. 

When submitting feedback, stakeholders can use the “Comments” function in the restricted Word documents provided by the NNHPD. Detailed instructions are available, ensuring that the process is straightforward and accessible. Alternatively, comments can be submitted via email with explicit references to the associated monographs. 

How to Participate in the Consultation 

Participating in the consultation process is simple. To review the documents and provide input, stakeholders are encouraged to follow these steps: 

  1. Access the Monographs: Visit the NNHPD’s official website, where links to Batch 4a monographs are available. 
  2. Download the Documents: Double-click the folder in your preferred language, download the monographs you would like to view and open them on your computer. 
  3. Enable Editing: The documents are in “Protected View,” so you will need to click “Enable Editing” to add comments. Click the Review tab in Word. 
  4. Submit Comments: Use the “New Comment” function in Word to provide feedback. Once complete, save the file and email it to the NNHPD at mailto:mnnhpd.consultation-dpsnso@hc-sc.gc.ca. 
  5. Alternatively, You can submit feedback via email, ensuring that each comment references the appropriate monograph. 

Building a Better Future for Hydration Products 

This consultation period is a defining moment for the future of natural hydration products. Participating allows stakeholders to shape regulations that will ultimately improve product quality, safety, and consumer trust. Whether you’re a product developer, a regulatory affairs expert, or a consumer advocate, your input could have a lasting impact on the health and wellness industry. 

Quality Smart Solutions emphasizes regulatory compliance is not just about meeting minimum standards; it’s about leading the market by offering products that consumers can trust. It’s important to underscore these consultations for companies looking to innovate in the natural health product space. Navigating these regulatory waters with expertise and precision is undoubtedly essential for success. 

Don’t Miss This Opportunity 

For stakeholders in the hydration product industry, the NNHPD’s Batch 4 consultation is a critical opportunity to help shape the future of homeopathic and topical hydration products. With the rising consumer demand for natural health products, this is your chance to ensure that your products meet the highest safety, efficacy, and quality standards. 

Submit your comments by October 2, 2024, for Batch 4a, and be part of this collaborative effort to improve the hydration product landscape. Your insights could make all the difference in helping consumers access the best natural health products. 

If you need help making your contribution, reach out to Quality Smart Solutions at 1(800)396-5144, and we will help you navigate this exciting new opportunity. 

Categories
Blog

7 Must-Know EFSA Novel Food Regulation Changes for 2025: You Need To Be Ready

Are your novel food products ready for the new European Food Safety Authority (EFSA) regulations? If you’re planning to enter the European market in 2025, significant updates to the EFSA novel food regulatory framework are on the horizon, effective from February 1, 2025. These changes will affect everything from risk assessments to labelling, sustainability, and more. Staying ahead of these updates could be the difference between success and costly delays.

This guide breaks down the fundamental regulatory changes and how your business can prepare for them. Plus, we’ll reveal how the common industry practice of partnering with experts can help you navigate these complex updates smoothly and avoid potential roadblocks.

What are these new EFSA Regulations?

1. Stricter Risk Assessments for Novel Foods

The EFSA is sharpening its focus on safety, particularly for foods created using cutting-edge technology like nanomaterials or synthetic biology.

Fundamental Change: Comprehensive assessments of potential toxicological, allergenic, and nutritional impacts.

What This Means: You should conduct long-term safety studies, especially for foods with novel production processes or bioactive components.

FAQ: Do I need new safety studies for already approved products? Answer: If your novel food includes new technology or production processes, you will need updated safety data that aligns with EFSA’s enhanced criteria.

2. Simplified Process for Traditional Foods from Non-EU Countries

Good news for those introducing traditional foods from outside the EU! EFSA is streamlining the process for these products if you can prove a safe consumption history.

Fundamental Change: Foods with at least 25 years of safe consumption in non-EU markets will benefit from a fast-tracked approval process.

What This Means: Less time-consuming reviews and easier entry into the European market.

FAQ: How do I prove my food has been consumed safely for 25 years? Answer: You must provide documented evidence like historical records, studies, or testimonials from recognized institutions.

3. Transparency in the Application Process

EFSA is taking steps to increase transparency, making more information about novel food applications accessible to the public.

Fundamental Change: A public database will feature safety evaluations and risk assessments.

What This Means: Consumers, researchers, and competitors can see the details of novel food approvals, increasing industry accountability.

4. Stricter Labeling and Health Claims Regulations

Misleading labels and exaggerated health claims will no longer be tolerated under EFSA’s new rules.

Fundamental Change: Labels must include clear information about the food’s novel nature, allergens, and proper preparation or consumption instructions.

What This Means: Ensure health claims are backed by scientific evidence to avoid non-approval or removal from the market.

FAQ: What happens if my product label is misleading? Answer: EFSA could reject or remove your product from the market, costing you time and money. Avoid exaggerated claims by relying on robust scientific evidence.

5. Protection of Proprietary Data

While EFSA is enhancing transparency, it’s also offering more protection for proprietary data submitted during novel food applications.

Fundamental Change: A five-year protection period for proprietary data ensures competitors can’t use your research for similar product approvals.

What This Means: You maintain a competitive advantage while benefiting from data exclusivity.

6. Sustainability Takes Center Stage

Sustainability is more important than ever, and EFSA’s updates reflect this by incorporating environmental factors into its review process.

Fundamental Change: Foods produced through sustainable practices—like alternative proteins and insect-based products—will receive added support in the approval process.

What This Means: Highlighting your food’s sustainability metrics (like carbon footprint) can boost your chances of approval.

FAQ: Can sustainability give my product an edge? Answer: Absolutely! Emphasizing low environmental impact practices aligns your product with EFSA’s sustainability goals and may lead to a priority review.

7. Increased Scrutiny of Supplements

If you’re producing supplements with novel ingredients, expect stricter rules.

Fundamental Change: New upper safety limits on bioactive compounds and mandatory consumer warnings.

What This Means: Supplements must now include clear usage instructions to prevent overconsumption.

How GRAS Experts Can Help

Navigating the intricate EFSA updates can be daunting, but GRAS Experts, a division of Quality Smart Solutions, can help your business comply with the new regulations. From assisting with long-term safety studies to advising on sustainability metrics, GRAS Experts ensure you meet all the latest requirements and successfully launch your novel food in the European market.

Don’t Wait Until it is too Late, Contact GRAS Experts Today

Ready to comply with EFSA’s 2025 regulations? With these updates around the corner, now is the time to ensure your novel food products meet all requirements. Whether providing long-term safety data, fast-tracking traditional foods, or crafting compliant labels, understanding the changes is critical to your success. With EFSA’s emphasis on sustainability, transparency, and public health, companies must stay proactive to stay competitive.

Don’t let complex regulations hold your product back—prepare now and position your business for success in 2025 and beyond.

References: 

https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2024.8966 

https://www.efsa.europa.eu/en/news/navigating-novel-foods-what-efsas-updated-guidance-means-safety-assessments 

https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2024.8961 

https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2024.8946 

Categories
Blog

Breaking News: Health Canada’s New GMP Guide for Natural Health Products – Are You Ready?

Health Canada has just released a draft Good Manufacturing Practices (GMP) guide for natural health products (NHPs), marking a monumental shift in how businesses will manufacture, package, label, and store their products. This guide introduces sweeping changes, the first since 2015, to ensure NHPs sold in Canada meet modern safety and quality standards. With updates that will affect every aspect of your production process, if your business does not fully understand or is not clear on these updates, the penalties for non-compliance could be serious. 

If you’re an NHP business or manufacturer, this draft GMP guide isn’t just another regulatory hurdle—it’s a roadmap to protecting your brand, safeguarding your consumers, and avoiding potentially severe consequences of non-compliance. So, what’s new, and how can you prepare? 

What’s Inside the Draft GMP Guide for NHPs? 

1. Major Focus on Quality Management Systems (QMS) 

In an era of growing consumer demand for transparency and safety, Health Canada’s new draft emphasizes the need for robust Quality Management Systems (QMS). For the first time, NHP manufacturers must align their practices with industries like pharmaceuticals and medical devices, where QMS is already essential. 

What does this mean for you? 

You’ll need to develop detailed procedures for everything—from sourcing raw materials to final product testing. Failing to implement a strong QMS can open the door to product recalls, tarnished reputation, and heavy fines. This updated system will ensure consistency, safety, and quality in your production process, protecting both your brand and your customers.

2. Enhanced Record-Keeping and Traceability 

With the new draft, record-keeping takes center stage. Detailed records will need to track each part of your production process, including where ingredients are sourced, batch numbers, production methods, and quality control tests. 

Why is this crucial? 

In the event of an audit or product recall, your business must show a clear trail of accountability—from raw materials to finished product. Enhanced traceability safeguards consumers and protects your business from regulatory non-compliance. Are your records ready for scrutiny? 

3. Rigorous Testing and Stability Requirements 

The draft introduces stricter testing and stability requirements to ensure that NHPs remain safe and effective throughout their shelf life. This means more frequent testing and precise documentation. 

What’s new? 

Expect Health Canada to ask for real-time stability tests, justification for rotational testing, and robust finished product testing practices. These measures guarantee your products deliver on their promises, ensuring long-term consumer trust. 

4. International Standards Now in Play 

The inclusion of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) is a game-changer. This allows greater international flexibility for companies sourcing products or ingredients from abroad. 

 

How does this help your business? 

By adopting these internationally recognized standards, Canada aims to modernize and smooth out inspections and ensure NHPs made or sourced globally meet Canadian safety and quality requirements. This opens up opportunities for businesses that rely on international suppliers while raising the bar substantially for compliance. 

5. Supplier and Ingredient Verification Now Critical 

Supplier verification is no longer optional—it’s mandatory. Health Canada expects NHP businesses to conduct thorough audits of suppliers, particularly those outside of Canada. This is where an NHP business can’t afford to miss anything and should use a partner fully versed in Health Canada regulatory compliance to help navigate this potentially risky juncture.  

What’s at stake? 

Businesses must maintain ongoing verification processes to ensure their ingredients meet Canadian standards. Those importing foreign-manufactured NHPs must pay particular attention to the new expectations for supplier audits. As a result of audits now being mandatory, demand for them has skyrocketed and wait times are getting longer. Don’t wait until it’s too late—get your supplier audits in order now. 

6. Push for Internal Audits and Continuous Improvement 

Additionally, Health Canada now requires NHP manufacturers to conduct regular internal audits, identifying compliance gaps before they become costly problems. 

For Health Canada, it is a way to make your business better 

By adopting a proactive approach to continuous improvement, you’ll not only comply with regulations but also enhance your production processes, ensuring consistent product quality and fewer regulatory issues. 

Why These Changes Matter to Your Business 

Canada’s natural health product industry is booming, and these new GMP guidelines aim to align with international standards and modern consumer expectations. Here’s why these updates are so important, and why any non-compliance is taken very seriously: 

  • Consumer Protection: Stricter controls ensure that products are safe, effective, and traceable from source to shelf. 
  • Global Harmonization: By incorporating international standards like PIC/S, Canadian businesses can more easily navigate cross-border trade. 
  • Enhanced Compliance: With internal audits, record-keeping, and stricter supplier verification, businesses can avoid compliance risks and focus on growth. 

But navigating these changes is no small task, and failure to comply could result in product recalls, loss of consumer trust, and even hefty penalties that could cripple your business or worse, bring lawsuits. So how can you prepare? 

How to Ensure Compliance with Health Canada’s New GMP Guide 

  1. Review Your Quality Management Systems (QMS):

Make sure your QMS covers the entire production process, from raw material sourcing to final product testing, and incorporates a culture of continuous improvement. 

  1. Conduct Thorough Supplier Audits:

Ensure your suppliers meet the new verification standards. For importers, this is especially critical to prevent non-compliance from international suppliers. 

  1. Strengthen Your Record-Keeping Systems:

Keep detailed, accessible records that track your entire production cycle, from ingredients to final products. 

  1. Prepare for More Rigorous Testing:

Update your product testing protocols to meet the new stability and testing requirements. This will ensure that your NHPs remain safe throughout their shelf life. 

  1. Engage with Health Canada:

Take advantage of the consultation period to review and comment on the draft guide. The consultation runs from October 15 to December 16, 2024—use this time to ask questions and prepare your business for what’s to come. 

Preparation in the key 

Health Canada’s draft GMP guide for natural health products is a major regulatory update designed to ensure transparency, safety, and quality across the NHP industry. With the global market for natural health products rapidly expanding, this new guide aims to protect consumers and align Canadian businesses with international best practices. 

By preparing for these changes now, you can stay ahead of the curve and ensure your products meet the highest standards, protecting your brand and your bottom line. 

How Quality Smart Solutions Can Help 

Quality Smart Solutions specializes in helping NHP businesses navigate the complexities of regulatory compliance. From implementing robust QMS to conducting supplier audits and ensuring proper documentation, our experts can guide your company through Health Canada’s new GMP guidelines and position you for long-term success. Don’t wait for these updates to take your business by surprise. Reach out to QSS now and position yourself for success. Fill out the form below to get started. 

 

Reference 

Health Canada. (2024). Consultation: Draft Good Manufacturing Practices Guide for Natural Health Products. Government of Canada. Retrieved from https://www.canada.ca/en/health-canada/programs/consultation-draft-good-manufacturing-practices-guide-natural-health-products/overview-about-nhp-quality-systems.html 

 

Categories
Blog

Understanding the Key Changes to Natural Health Product (NHP) Labeling in Canada

Natural health products (NHPs) are widely used in Canada, ranging from vitamins, minerals, and herbal remedies to probiotics and homeopathic medicines. As these products play a vital role in promoting health and wellness, clear and accurate labeling is essential to ensure consumers can make informed decisions about the products they use.

To strengthen consumer safety and product transparency, Health Canada has introduced new labeling regulations for NHPs that align closely with non-prescription drug labeling standards. These changes are aimed at improving readability, consistency, and access to important product information. Below is a comprehensive breakdown of the most significant changes to NHP labeling and what they mean for manufacturers, retailers, and consumers.

Why Health Canada Updated NHP Labeling Requirements

The updated regulations reflect a growing concern for consumer safety, particularly as the market for natural health products continues to expand. With so many products available, it is essential that consumers have access to clear and concise information regarding ingredients, usage, risks, and allergens. The goal of these updates is to provide standardized and user-friendly labels that enhance transparency and facilitate better decision-making.

In addition, these changes address challenges identified through consumer feedback, industry consultations, and research on product labeling practices. By ensuring that NHP labels follow stringent standards, Health Canada is also working to increase confidence in the products available on the market.

Key NHP Labeling Changes: An Overview

The new NHP labeling rules include several critical changes designed to improve clarity, transparency, and accessibility. Below are the most important elements of these changes:

1. Product Facts Table

One of the most significant changes to NHP labeling is the introduction of a standardized Product Facts Table. This table is similar to the Drug Facts Table found on non- prescription drugs and serves as a quick reference for consumers to find essential product information.

  •  Required Information: The Product Facts Table must include key details such as active ingredients, dosage instructions, uses, warnings, and potential allergens.
  • Format: The table must follow a consistent format, making it easier for consumers to compare products and access relevant information quickly.
  • Importance: This change ensures that important safety information is highlighted and easily accessible, especially for consumers with specific health concerns or allergies.

2. Minimum Font Size

The updated regulations set strict requirements for minimum font sizes to improve the legibility of NHP labels.

  • Why It Matters: Previously, some NHP labels were difficult to read due to small fonts, especially for older consumers or those with vision impairments.
  • New Standards: The new rules specify that key information, such as the product name, dosage, and warnings, must be printed in a minimum font size to enhance readability. This requirement applies to both the Product Facts Table and other parts of the label.

3. Use of Plain Language

Another critical update is the requirement for labels to use plain language. This change is aimed at ensuring that the health claims, warnings, and instructions provided on NHP labels are written in simple, easy-to-understand terms.

  • Health Claims: Label must list at least one recommended purpose and must use the exact wording on your terms of market authorization.
  • Warnings and Risk Information: Warnings about potential risks, side effects, or interactions with other products must be communicated as they are on your terms of market authorization and must be in specific order under the new regulations.

4. Allergen Disclosure

Allergen labeling is a critical aspect of food and natural health product regulations, and the new NHP rules enhance allergen disclosure to align with food labeling requirements.

  • Required Information: NHP labels must clearly identify potential allergens such as

peanuts, tree nuts, gluten, and other common allergens that may be present in the product.

  • Why It’s Important: This change helps protect consumers with allergies and ensures they can make safe choices when selecting products. Clear allergen disclosure also prevents accidental exposure, which could lead to serious health consequences.

5. Expiry Date and Lot Number

Consumers rely on product labels to determine the shelf life and safety of natural health products. The updated regulations require that expiry dates and lot numbers be displayed more prominently on NHP labels.

  • Visibility: Expiry dates must be easy to locate and read, ensuring consumers are aware of when the product may lose its efficacy or safety by expressing in a specific format.
  • Lot Numbers: Lot numbers are essential for tracking purposes, especially in the case of product recalls. This ensures that manufacturers, retailers, and consumers can identify specific batches of products quickly and efficiently.

6. Standardized Risk Information

In addition to clear instructions on product use, labels must now include standardized risk information that outlines any potential side effects, interactions, or precautions associated with the NHP.

  • Risk Information: Cautionary statements must be clearly stated as they are written on the terms of market authorization. Subsections such as Allergens, Flammability warning, Choking Warning, and Keep out of reach of children may be included on the Product Facts Table.

7. Contact Information

The updated labeling regulations also require NHP labels to include contact information for the license holder.

  • Why This Matters: Including a phone number or email address or website ensures that consumers can quickly reach out to the company if they have questions about the product or wish to report any adverse reactions. This promotes greater accountability and transparency in the NHP industry.

8. Transitional Period for Compliance

License holders are given a transitional period of up to 3 years from the effective date of the new label regulations to comply with the new labeling requirements, allowing time to adjust packaging and update label designs.

  • Products with NPNs issued before June 21, 2025: They will have until June 21, 2028 to comply with the new label regulations.
  • Products licensed on or after June 21, 2025: Labels must comply with the new label regulations immediately. No grace period

What the Changes Mean for Consumers

These new labeling requirements have been implemented with the consumer in mind. By standardizing how information is presented on NHP labels, Health Canada aims to

improve the consumer experience and ensure that all individuals have access to accurate, easy-to-understand product information.

1. Enhanced Clarity and Transparency

Consumers will benefit from clearer labels that provide straightforward, easy-to-find information about product usage, risk information and ingredients. The new Product Facts Table makes it simpler to compare products and understand essential details about their use and safety.

2. Improved Safety for Vulnerable Populations

With better allergen disclosures, clearer warnings, and standardized expiry date formats, consumers can make safer, more informed choices when selecting natural health products. This is particularly important for individuals with allergies, chronic health conditions, or those taking other medications.

3. Easier Access to Product Information

The inclusion of plain language, readable fonts, and contact information ensures that all consumers, regardless of literacy level or health knowledge, can access the information they need to use NHPs safely and effectively.

Implications for Manufacturers and Retailers

The updated labeling regulations present both challenges and opportunities for manufacturers and retailers in the NHP industry. While the changes require adjustments to packaging and label design, they also offer several long-term benefits.

1. Increased Consumer Trust

By adhering to the new labeling standards, manufacturers can enhance the trust consumers place in their products. Clear, transparent labeling signals that the company is committed to safety and regulatory compliance, boosting brand reputation.

2. Streamlined Compliance

While the new regulations may require an initial investment in redesigning labels, they provide a standardized framework for compliance, reducing ambiguity and ensuring that all manufacturers are held to the same standards.

3. Competitive Advantage

Companies that implement these labeling changes promptly and effectively may gain a competitive advantage by being seen as early adopters of best practices in the NHP industry. Consumers are more likely to trust and purchase products that prioritize safety and transparency.

4. Need for Regulatory Guidance

To ensure compliance, manufacturers and license holders may need to seek guidance from regulatory experts who are familiar with the updated labeling requirements. This can help streamline the process and avoid costly mistakes that could lead to product recalls or regulatory penalties.

Why NHP License Holders should start Updating Labels Now

Though current NHP license holders have until 2028 to update their labels to meet the new label requirements the reason to start the changes now is consumer clarity. Having two types of label formats under the same brand will inevitably create confusion in the short term. Major retailers will likely require current NPN holder brands to comply with the new label regulations much sooner than the 2028 deadline. Managing packaging inventory and product turns will be key to developing a roll out strategy for new NHP label implementation.

Also, NHPs with product license/s issued on or after June 21 2025, must meet the new labeling requirements.

A Positive Step for Consumer Safety and Transparency

The new NHP labeling requirements represent a significant step forward in improving consumer safety, transparency, and product consistency in Canada. By introducing standardized labeling practices, Health Canada is ensuring that natural health products are labeled in a way that is clear, concise, and accessible to all consumers.

For manufacturers and retailers, these changes may require an investment of time and resources to ensure compliance, but the long-term benefits—both in terms of consumer trust and regulatory alignment—are substantial. As the natural health product market continues to grow, the importance of clear and transparent labeling will only increase, making these updates a vital component of public health and consumer protection.

How Quality Smart Solutions Can Help

With thousands of natural health product registrations and NHP label reviews we can ensure your packaging complies with the new NHP label regulations. We can help strategize the optimal time to begin this process if your products are licensed before the effective date so you minimize packaging liability. Reach out to us today by completing the form below.

Reference: https://www.canada.ca/en/health-canada/services/drugs-health- products/natural-non-prescription/legislation-guidelines/guidance- documents/labelling.html

Subscribe to global regulatory updates

Don't miss updates from Health Canada and FDA.

If you are looking for the latest regulatory updates or want the newest regulatory requirements guides, please leave your email and we'll keep you posted.

What service are you interested in? *
We use cookies to display personalized content, analyze site traffic, provide recommendations, and ensure you have a great browsing experience. By continuing to use our site, you consent to our use of cookies. Privacy Policy.